ALK-Abello (Buy, TP: DKK970.00) - All about ODACTRA
As ALK reaffirmed the 2017 guidance in December, we expect focus in the Q4 results (due at 08:00 CET on 6 February) to be on be on the detailed 2018 guidance, and not least initial feedback from the US launch of ODACTRA. We expect 2018 guidance in line with the preliminary outlook given in conjunction with the strategy update in December. We reiterate our BUY recommendation and DKK970 target price.
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.